Company intelligence / Profile preview

TL Revolution

Cambridge, Massachusetts, United Statestlrevolution.com ↗

Ownership: Private
Employees: ~1
Development stage: Other

Overview

TL Revolution develops advanced data analysis software using state-of-the-art causal machine learning methods—specifically targeted learning, TMLE, and super learning—to improve the precision and reliability of treatment effect evaluation in clinical trials and real-world studies. Their tools are used by pharmaceutical companies, regulatory agencies like the FDA, and other stakeholders to drive more accurate decision-making in healthcare research.

Modalities: Non-pharmacological therapy (data analytics platform; not a therapeutic developer)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

No specific major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on TL Revolution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TL Revolution.

Explore the full profile